Theragenics (FRA:THX) Dividend Payout Ratio : 0.00 (As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Theragenics Dividend Payout Ratio?

Theragenics's dividend payout ratio for the months ended in Jun. 2013 was 0.00.

The historical rank and industry rank for Theragenics's Dividend Payout Ratio or its related term are showing as below:

FRA:THX's Dividend Payout Ratio is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 0.43
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-19), the Dividend Yield % of Theragenics is 0.00%.

Theragenics's Dividends per Share for the months ended in Jun. 2013 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Theragenics Dividend Payout Ratio Historical Data

The historical data trend for Theragenics's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theragenics Dividend Payout Ratio Chart

Theragenics Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dividend Payout Ratio

Get a 7-Day Free Trial

Theragenics Quarterly Data
	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Theragenics's Dividend Payout Ratio

For the Medical Devices subindustry, Theragenics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theragenics's Dividend Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theragenics's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Theragenics's Dividend Payout Ratio falls into.

Theragenics Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Theragenics's Dividend Payout Ratio for the fiscal year that ended in Dec. 2012 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2012 )	/	EPS without NRI (A: Dec. 2012 )
	=	0	/	0.053
	=	0.00

Theragenics's Dividend Payout Ratio for the quarter that ended in Jun. 2013 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2013 )	/	EPS without NRI (Q: Jun. 2013 )
	=	0	/	0
	=	N/A

Theragenics (FRA:THX) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Theragenics Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Theragenics's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Theragenics (FRA:THX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theragenics Corporation (FRA:THX) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.theragenics.com

Theragenics Corporation is a Delaware Corporation formed in 1981. It is a medical device company serving the surgical products and cancer treatment markets, operate in two business segments; the surgical products segment and the brachytherapy seed segment. The Company's surgical products business manufactures markets and sells disposable devices utilized in certain surgical procedures. Its brachytherapy seed business manufactures markets and sells radioactive 'seeds' utilized in the treatment of early stage prostate cancer. Its surgical products business was built through the acquisitions of CP Medical Corp. in May 2005, Galt Medical Corporation in August 2006, and NeedleTech Products, Inc. in July 2008. The Company manufactures almost 3,500 products in this business as part of three broad product platforms; wound closure, vascular access and specialty needles. It serves a number of markets and applications, including, among other areas, interventional cardiology, interventional radiology, vascular surgery, orthopedics, plastic surgery, dental surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. With the exception of veterinary sutures, its surgical products hold relatively small market shares. Its products include both finished goods and components. The Company's products are sold mainly to original equipment manufacturers and to a network of distributors. The Company's facilities and operations are subject to extensive environmental, nuclear, regulatory and occupational health and safety laws at the federal, state and local levels. It is also subject to similar foreign laws and regulations under certain circumstances when its products are distributed outside of the United States.

Theragenics (FRA:THX) Headlines

No Headlines